Mental health screening in Cystic Fibrosis as an intervention: Patient and caregiver feedback on improving these processes.

Autor: Landau EC; The Graub CF Center, Pulmonary Institute, Schneider Children's Medical Center, Petah Tikva, Israel. Electronic address: eclandau@gmail.com., Verkleij M; Department of Pediatric Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Graziano S; Unit of Clinical Psychology, Department of Neurological Sciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Quittner AL; Behavioral Health Systems Research, Miami, FL, USA., Georgiopoulos AM; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA., Smith BA; Department of Psychiatry & Pediatrics, University of Buffalo School of Medicine, Buffalo, USA., Schechter MS; Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Virginia, USA., Abbott J; School of Psychology, University of Central Lancashire, UK.
Jazyk: angličtina
Zdroj: Respiratory medicine [Respir Med] 2022 Oct; Vol. 202, pp. 106955. Date of Electronic Publication: 2022 Aug 27.
DOI: 10.1016/j.rmed.2022.106955
Abstrakt: Competing Interests: Declaration of competing interest Dr Edwina Landau reports speaker reimbursement from the European Cystic Fibrosis Society. Dr Marieke Verkleij reports grants from the Dutch Cystic Fibrosis Foundation, speaker and travel reimbursement from the European Cystic Fibrosis Society and grants from Vertex Pharmaceuticals. Dr Anna Georgiopoulos reports personal fees and travel reimbursement from Cystic Fibrosis Australia; grants, personal fees, and travel reimbursement from Cystic Fibrosis Foundation; grants from the Dutch Cystic Fibrosis Foundation; travel reimbursement from the European Cystic Fibrosis Society; personal fees from Johns Hopkins University/DKBmed; personal fees from Saudi Pediatric Pulmonology Association; grants and personal fees from Vertex Pharmaceuticals. Dr Alexandra Quittner reports grants from the NIH, CF Foundation, and the American Cochlear Implant Alliance; grant and travel reimbursement from Cystic Fibrosis Australia; consulting fees from Vertex Pharmaceuticals and Insmed, Inc. Dr Michael Schechter reports research grants from the NIH, CFF, Abbvie, GlaxoSmithKline, Vertex, consulting fees from Astra-Zeneca and CFF, speaking fees from Sanofi Pasteur.
Databáze: MEDLINE